Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health
Bob Herman

FDA approves another new migraine medicine

Eli Lilly has two prominent migraine drugs now. Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.

The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.